Skip to main content
. 2016 Dec 7;18:91. doi: 10.1186/s12968-016-0311-9

Table 2.

Pompe disease related patient characteristics

Pompe
N = 17
Age at diagnosis, years 31 ± 14
Disease duration, years 19 ± 14
Hypoventilation, n (%) 9 (53)
Mechanical ventilatory support, n (%) 8 (47)
Severely impaired FVC*, n (%) 7 (44)
Limb girdle weakness, n (%) 16 (94)
Walking aid necessary, n (%) 3 (18)
Six minute walk test, m 410 (234–512)
Enzyme replacement therapy, n (%) 12 (71)
Duration of enzyme therapy, months 72 (29–83)

* - <50% of the predicted value; FVC-upright forced vital capacity